MAPT and Alzheimer disease: Tau load in the hippocampus of the case FTDP1, as determined by immunohistochemistry with AT8, was comparable to that found in the Alzheimer’s disease cases (ca. 30%), whereas in the cortical areas it was considerably lower (ca. 15%).